SEQUENOM INC | 3,126 Euro | +0,126 +4,2 % | |
| WKN: A0J23S ISIN: US8173374054 Ticker-Symbol: QNMA | Frankfurt | 24.05.13 | 15:37 Uhr |
Branche BiotechnologieAktienmarkt NASDAQ Biotech |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 22.05. | Sequenom: Plenty Of Room To Run | 5 | Seeking Alpha | |
| 17.05. | Sequenom's Management Presents at Bank of America Merrill Lynch Health Care Conference (Transcript) | 3 | Seeking Alpha | |
| 13.05. | Sequenom shares advance as analyst lifts rating | 12 | Yahoo-USA | |
| 13.05. | Sequenom Up 7.6%, Shares Break Through Resistance | 3 | SmarTrend | |
| 10.05. | Traders Get Bullish on Shares of Sequenom, Shares Up 16.8% | 14 | SmarTrend | |
| 10.05. | Sequenom's CEO Discusses Q1 2013 Results - Earnings Call Transcript | 8 | Seeking Alpha | |
| 09.05. | SEQUENOM INC - 8-K, Current Report | 7 | SEC Filings | |
| 09.05. | Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013 | 45 | PR Newswire | |
| SAN DIEGO, May 9, 2013 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported revenue of $38.5 million for the first... Mehr lesen zu: Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013 | ||||
| 08.05. | Leveraging Sequenom's Upcoming Earnings Volatility | 2 | Seeking Alpha | |
| 08.05. | Sequenom Announces Participation At The Bank Of America Merrill Lynch Health Care Conference | 28 | PR Newswire | |
| SAN DIEGO, May 8, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's... Mehr lesen zu: Sequenom Announces Participation At The Bank Of America Merrill Lynch Health Care Conference | ||||
| 25.04. | Sequenom, Inc. Announces Date of First Quarter 2013 Financial Results and Conference Call | 34 | PR Newswire | |
| SAN DIEGO, April 25, 2013 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced... Mehr lesen zu: Sequenom, Inc. Announces Date of First Quarter 2013 Financial Results and Conference Call | ||||
| 17.04. | Scenario Analysis Yields 15% Upside For Sequenom | 5 | Seeking Alpha | |
| 16.04. | Sequenom CMM Achieves Milestone Of 100,000 MaterniT21' Plus Tests Processed | 42 | PR Newswire | |
| SAN DIEGO, April 16, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that earlier this month, its wholly... Mehr lesen zu: Sequenom CMM Achieves Milestone Of 100,000 MaterniT21' Plus Tests Processed | ||||
| 12.04. | Today's Technical View on Sequenom, Peregrine Pharma, Inovio Pharma, and Onyx Pharma | 83 | PR Newswire | |
| LONDON, April 12, 2013 /PRNewswire/ --
Markets showed broad gains as these continued their upward ascent. The new earnings season has started on a positive note and provided a good fillip to the... Mehr lesen zu: Today's Technical View on Sequenom, Peregrine Pharma, Inovio Pharma, and Onyx Pharma | ||||
| 05.04. | Upgrade Alert for Sequenom | 9 | SmarTrend | |
| 30.03. | Shares of Sequenom Rank the Highest in Terms of Debt to Equity Ratio in the Life Sciences Tools & Services Industry | 9 | SmarTrend | |
| 21.03. | Sequenom, Inc. Announces The Availability Of Heredi-T' Cystic Fibrosis Carrier Screening LDT Through Sequenom CMM | 44 | PR Newswire | |
| SAN DIEGO, March 21, 2013 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that Sequenom Center for Molecular... Mehr lesen zu: Sequenom, Inc. Announces The Availability Of Heredi-T' Cystic Fibrosis Carrier Screening LDT Through Sequenom CMM | ||||
| 19.03. | Sequenom's RTP lab to open this year, advance Down syndrome research | 7 | bizjournals | |
| 19.03. | Sequenom Delays 2012 10-K | 8 | Motley Fool | |
| 18.03. | Sequenom (SQNM) Delays 10-K Filing for FY12 | 6 | StreetInsider.com | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| MORPHOSYS | 34,50 | -0,58 % | MorphoSys AG: Veröffentlichung gem. § 26 Abs.1 WpHG mit dem Ziel der europaweiten Verbreitung |
| EVOTEC | 2,772 | +0,22 % | Evotec-Aktie: Jetzt einsteigen! |
| MEDIGENE | 0,915 | +2,92 % | Medigene: Rating wird erneuert |
| AGENNIX | 0,057 | -40,62 % | Agennix AG gibt Liquidation bekannt |
| STEMCELLS | 1,428 | +2 % | New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry's Growth in 2012 / Five Star Equities Provides Stock Research on NuPathe and StemCells |
